Bouffet, E., Sudhaman, S., Chung, J., Kelly, J., Coblentz, A., Edwards, M., Lipman, T., Zhang, C., Ercan, A. B., Sambira, L., Bendel, A., Bielack, S., Koustenis, E., Blumenthal, D., Bowers, D., Broniscer, A., Bronsema, A., Carroll, S., Chiaravalli, S., Cole, K., Constantini, S., De Mola, R. L., Dunn, G., Fröjd, C., Gass, D., Gauvain, K., George, B., Hijiya, N., Hoffman, L., Knipstein, J., Laetsch, T., Larouche, V., Lassaletta, A., Lindhorst, S., Lossos, A., Luna-Fineman, S., Magimairajan, V., Mason, G., Mason, W., Massimino, M., Mordechai, O., Opocher, E., Oren, M., Osborn, M., Reddy, A., Remke, M., Roy, S., Sabel, M., Samuel, D., Schneider, K., Sen, S., Stearns, D., Sumerauer, D., Thomas, G., Tomboc, P., Van Damme, A., Wierman, M., Winer, I., Yen, L. Y., Zapotocky, M., Ziegler, D., Zimmermann, S., Dvir, R., Rechavi, G., Durno, C., Aronson, M., Taylor, M., Dirks, P., Pugh, T., Shlien, A., Hawkins, C., Morgenstern, D., & Tabori, U. (n.d.). iMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY. Neuro-oncology, 22, iii363. http://access.bl.uk/ark:/81055/vdc_100117805403.0x000032